EVH Klasa A Evolent Health, Inc Class A Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$3,46
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$2,1052tyg. minimum
$8,4652tyg. maksimum
P/E (TTM)
-0.8
EPS (TTM)
$-4.57
Przychody (TTM)
$2.10B
Twoje odznaki
Zakres 52 tyg.
$2–$8
Ocena Analityków
BUY
Cena Docelowa
$6
P/E
-0.8
ROE
-79.0%
Marża Zysku Netto
-24.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
EVH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.46
P/E (TTM)
-0.8
EPS (TTM)
$-4.57
Przychody (TTM)
$2.10B
ROE (TTM)
-79.0%
D/E Dług/Kapitał (MRQ)
2.5
Zakres 52 tyg.
$2–$8
EVH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$1.88B2017-12-31 → 2025-12-31
EPS$-5.072017-12-31 → 2025-12-31
Wolny przepływ pieniężny·2017-12-31 → 2019-12-31
Marża netto-24.1%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | EVH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -0.8średnia z 5 lat ≈-48.8 | ≈-48.8 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | EVH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -20.4%średnia z 5 lat ≈-9.4% | ≈-9.4% | 2.7% | Słaby | |
| Marża EBITDA (TTM) | -15.1%średnia z 5 lat ≈-3.6% | ≈-3.6% | 4.3% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -23.9%średnia z 5 lat ≈-11.4% | ≈-11.4% | -4.6% | Zgodnie z | |
| Marża Zysku Netto (TTM) | -24.1%średnia z 5 lat ≈-11.7% | ≈-11.7% | -3.9% | Zgodnie z | |
| ROA (TTM) | -22.8%średnia z 5 lat ≈-7.1% | ≈-7.1% | -2.6% | Słaby | |
| ROE (TTM) | -79.0%średnia z 5 lat ≈-21.2% | ≈-21.2% | 2.4% | Słaby | |
| ROIC | -29.6%średnia z 5 lat ≈-7.8% | ≈-7.8% | -14.9% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | EVH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 2.5średnia z 5 lat ≈0.9 | ≈0.9 | 0.1 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 1.2średnia z 5 lat ≈1.1 | ≈1.1 | 1.5 | Poniżej średniej | |
| Quick Ratio (Wskaźnik Szybkości) | 1.2średnia z 5 lat ≈1.0 | ≈1.0 | 1.0 | Zgodnie z | |
| Dług długoterminowy / Kapitał własny (MRQ) | 2.5średnia z 5 lat ≈0.8 | ≈0.8 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | EVH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -26.6%średnia z 5 lat ≈19.2% | ≈19.2% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 11.5%średnia z 5 lat ≈27.1% | ≈27.1% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 15.2% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | EVH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 0.6 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 5.2średnia z 5 lat ≈5.6 | ≈5.6 | 7.0 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$446.7K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-5.7%
Następny raport
Lis 04, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 6, 2026 | $0.02 | $-0.02 | 183.7% |
| 31 marca 2026 | $-0.02 | $-0.05 | 61.4% | |
| 31 grudnia 2025 | $0.08 | $0.06 | 37.7% | |
| 30 września 2025 | $0.05 | $0.11 | -52.6% | |
| 30 czerwca 2025 | $-0.10 | $0.08 | -226.4% | |
| 31 marca 2025 | $0.06 | $0.10 | -37.8% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $908M | $925M | $687M | $627M | $435M | $254M | |
| Cost of Revenue | $1.48B | $2.19B | $1.50B | $1.04B | $658M | · | · | · | · | · | |
| R&D Expense | · | · | · | · | $16M | $15M | $20M | $18M | $17M | $11M | |
| SG&A Expense | $304M | $263M | $358M | $269M | $219M | $210M | $236M | $235M | $206M | $161M | |
| Operating Expenses | $2.29B | $2.60B | $2.04B | $1.35B | $950M | $1.19B | $996M | $675M | $508M | $492M | |
| Operating Income | $-410M | $-40M | $-71M | $4M | $-42M | $-263M | $-309M | $-47M | $-73M | $-237M | |
| Interest Expense | · | · | $54M | $16M | $25M | $28M | $15M | $5M | $4M | $247.0K | |
| Interest Income | $4M | $6M | $5M | $1M | $407.0K | $3M | $3M | $3M | $2M | $970.0K | |
| Other Non-op | $249.0K | $241.0K | $-543.0K | $57.0K | $-146.0K | $-118.0K | $-489.0K | $109.0K | $171.0K | $4.0K | |
| Pretax Income | $-535M | $-63M | $-202M | $-62M | $-30M | $-331M | $-330M | $-54M | $-76M | $-238M | |
| Income Tax | $-126.0K | $-1M | $-89M | $-43M | $483.0K | $-2M | $-23M | $40.0K | $-7M | $-11M | |
| Net Income | $-535M | $-62M | $-113M | $-19M | $-38M | $-334M | $-306M | $-53M | $-61M | $-160M | |
| EPS (Basic) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | · | $-0.94 | $-3.55 | |
| EPS (Diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | · | $-0.94 | $-3.55 | |
| Shares (Basic) | 114,208,000 | 114,682,000 | 111,251,000 | 93,699,000 | 86,067,000 | 84,928,000 | 82,364,000 | · | 64,351,000 | 45,031,000 | |
| Shares (Diluted) | 114,208,000 | 114,682,000 | 111,251,000 | 93,699,000 | 86,067,000 | 84,928,000 | 82,364,000 | · | 64,351,000 | 45,031,000 | |
| EBITDA | $-294M | $78M | $52M | $71M | $18M | $-209M | $-246M | $-3M | $-40M | $-220M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $152M | $104M | $193M | $188M | $266M | $319M | $101M | $228M | $238M | $135M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $44M | |
| Receivables | $310M | $415M | $447M | $255M | $131M | $124M | $76M | $80M | $49M | $41M | |
| Prepaid Expense | $19M | $29M | $30M | $21M | $51M | $56M | $28M | $23M | $8M | $11M | |
| Current Assets | $506M | $607M | $684M | $478M | $524M | $548M | $229M | $488M | $378M | $265M | |
| PP&E (Net) | $81M | $73M | $78M | $88M | $81M | $86M | $85M | $74M | $51M | $31M | |
| PP&E (Gross) | $287M | $253M | $237M | $238M | $200M | $175M | $140M | $105M | $65M | $36M | |
| Accum. Depreciation | $206M | $180M | $159M | $150M | $119M | $89M | $55M | $32M | $14M | $5M | |
| Goodwill | $694M | $1.14B | $1.12B | $723M | $426M | $349M | $566M | $768M | $628M | $627M | |
| Intangibles | $585M | $680M | $752M | $443M | $280M | $265M | $308M | $335M | $241M | $259M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $15M | $9M | $10M | |
| Total Assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B | $1.37B | $1.50B | $1.72B | $1.31B | $1.20B | |
| Accounts Payable | $60M | $96M | $48M | $57M | $96M | $32M | $37M | $147M | $43M | $44M | |
| Accrued Liabilities | $66M | $66M | $150M | $111M | $107M | $73M | $33M | $49M | $30M | $29M | |
| Short-term Debt | $0 | $171M | $0 | $0 | · | · | · | · | · | · | |
| Current Liabilities | $385M | $716M | $674M | $433M | $445M | $403M | $193M | $269M | $133M | $132M | |
| Capital Leases | $4M | $25M | $38M | $56M | $58M | $63M | $69M | $0 | · | · | |
| Deferred Tax | $8M | $11M | $13M | $5M | $1M | $679.0K | $2M | $25M | $2M | $21M | |
| Other Non-current Liabilities | $8M | $3M | $4M | $5M | $6M | $22M | $12M | $17M | $10M | $15M | |
| Total Liabilities | $1.48B | $1.35B | $1.43B | $958M | $726M | $752M | $569M | $533M | $266M | $288M | |
| Long-term Debt | · | · | · | · | $216M | $290M | $294M | $221M | $121M | $120M | |
| Total Debt | $971M | $662M | $597M | $413M | $216M | $290M | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $908.0K | $859.0K | · | · | · | · | |
| Paid-in Capital | $1.79B | $1.80B | $1.81B | $1.49B | $1.34B | $1.23B | $1.17B | $1.09B | $924M | $555M | |
| Retained Earnings | $-1.32B | $-781M | $-719M | $-606M | $-627M | $-589M | $-252M | $50M | $86M | $147M | |
| Treasury Stock | $61M | $21M | $21M | $21M | $21M | $21M | $0 | · | · | · | |
| AOCI | $-3M | $-2M | $-1M | $-1M | $-362.0K | $-278.0K | $-234.0K | $-182.0K | $0 | · | |
| Stockholders' Equity | $415M | $1.00B | $1.07B | $859M | $694M | $620M | $929M | $1.14B | $1.01B | $703M | |
| Liabilities + Equity | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B | $1.37B | $1.50B | $1.72B | $1.31B | $1.20B | |
| Shares Outstanding | · | · | · | · | · | · | 84,588,629 | · | · | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $116M | $118M | $123M | $67M | $60M | $61M | $61M | $45M | $32M | $17M | |
| Stock-based Comp | $40M | $40M | $41M | $34M | $17M | $15M | $16M | $18M | $20M | $19M | |
| Deferred Tax | $-15M | $-19M | $-54M | $2M | $-10M | $-48M | $-32M | $-17M | $100.0K | $-11M | |
| Amort. of Intangibles | $90M | $88M | $91M | $35M | $29M | $32M | $37M | $27M | $23M | $12M | |
| Restructuring | · | · | · | $0 | $7M | $1M | $0 | $0 | · | · | |
| Other Non-cash | $433M | $-59M | $146M | $-96M | $10M | $290M | $215M | $-13M | $-20M | $99M | |
| Operating Cash Flow | $39M | $19M | $143M | $-12M | $39M | $-16M | $-43M | $-21M | $-28M | $-36M | |
| CapEx | · | · | · | · | · | · | $36M | $40M | $28M | $16M | |
| Investing Cash Flow | $-233.0K | $-63M | $-416M | $-259M | $-16M | $261M | $-182M | $-160M | $-12M | $-97M | |
| Debt Issued | · | · | $647M | $220M | $0 | $30M | · | · | · | · | |
| Net Debt Issued | · | $0 | $183M | $220M | · | · | · | · | · | · | |
| Stock Repurchased | $40M | $0 | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | $-40M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-36M | $-565.0K | $281M | $132M | $-30M | $-12M | $-36M | $274M | $166M | $150M | |
| Net Change in Cash | $2M | $-45M | $8M | $-140M | $-7M | $233M | $-260M | $93M | $125M | $18M | |
| Taxes Paid | $3M | $1M | $5M | $1M | $551.0K | $10M | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-78M | $-60M | $-56M | $-51M | |
| Levered FCF | · | · | · | · | · | · | $-92M | $-66M | $-59M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -21.9% | -1.6% | · | · | -4.7% | -26.5% | -36.2% | -7.6% | · | -32838.0% | |
| Net Margin | -28.5% | -2.4% | · | · | -4.1% | -32.7% | -35.7% | -8.4% | · | -22094.3% | |
| Pretax Margin | -28.5% | -2.5% | · | · | -3.3% | -33.0% | -38.6% | -8.6% | · | -32853.8% | |
| EBITDA Margin | -15.7% | 3.0% | · | · | 1.9% | -20.5% | -29.0% | -0.47% | · | -30455.7% | |
| ROA | -24.1% | -2.4% | -5.0% | -1.2% | -2.8% | -23.3% | -18.8% | -3.5% | -4.8% | -14.4% | |
| ROE | -81.5% | -6.0% | -10.4% | -2.2% | -5.8% | -43.2% | -29.2% | -4.9% | -7.1% | -23.6% | |
| ROIC | -29.6% | -2.4% | -2.4% | 0.09% | -4.7% | -29.4% | -31.1% | -4.2% | -6.6% | -32.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 0.8 | 1.0 | 1.1 | 1.2 | 1.4 | 1.2 | 1.8 | 2.8 | 2.0 | |
| Quick Ratio | 1.2 | 0.7 | 0.9 | 1.0 | 0.9 | 1.2 | 0.9 | 1.1 | 2.2 | 1.7 | |
| Debt / Equity | 2.3 | 0.7 | 0.6 | 0.5 | 0.3 | 0.5 | · | · | · | · | |
| LT Debt / Equity | 2.3 | 0.5 | 0.6 | 0.5 | 0.3 | 0.4 | · | · | · | · | |
| Interest Coverage | · | · | -1.3 | 0.2 | -1.7 | -9.6 | -21.1 | -8.7 | -20.0 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | · | · | 0.7 | 0.7 | 0.5 | 0.4 | · | 0.0 | |
| Receivables Turnover | 5.2 | 5.9 | · | · | 5.8 | 10.1 | 10.9 | 9.7 | · | 0.0 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $16.43 | $22.28 | · | · | $10.55 | · | · | · | · | $0.02 | |
| Cash Flow / Share | $0.34 | $0.16 | $1.28 | $-0.12 | $0.45 | · | · | · | $-0.43 | $-0.79 | |
| EPS (TTM) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | $-0.65 | $-0.94 | $-3.55 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -26.6% | 30.1% | 45.3% | 48.9% | -1.8% | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.5% | 41.2% | 28.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.88B | $2.55B | $1.96B | $1.35B | $908M | $925M | $687M | $627M | $435M | $254M | |
| Net Income TTM | $-535M | $-62M | $-113M | $-19M | $-38M | $-334M | $-306M | $-53M | $-61M | $-160M | |
| P/E | -0.8 | -13.9 | -25.8 | -140.4 | -62.9 | -4.1 | -2.5 | -30.7 | -13.1 | -4.2 | |
| Earnings Yield | -126.8% | -7.2% | -3.9% | -0.71% | -1.6% | -24.6% | -40.6% | -3.3% | -7.6% | -24.0% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $653M | $496M | $469M | $480M | $444M | $484M | $647M | $621M | $647M | $640M | $556M | $511M | $469M | $428M | $382M | $353M | |
| Cost of Revenue | $572M | $412M | $371M | $380M | $344M | $381M | $571M | $541M | $540M | $536M | $454M | $387M | $352M | $310M | $299M | $267M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| SG&A Expense | $69M | $73M | $73M | $78M | $75M | $78M | $48M | $67M | $69M | $79M | $81M | $97M | $90M | $90M | $83M | $69M | |
| Operating Expenses | $662M | $507M | $877M | $479M | $445M | $485M | $665M | $638M | $639M | $653M | $577M | $529M | $491M | $438M | $384M | $340M | |
| Operating Income | $-10M | $-11M | $-408M | $886.0K | $-1M | $-2M | $-19M | $-16M | $8M | $-13M | $-21M | $-18M | $-22M | $-10M | $-2M | $13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $15M | $14M | $13M | · | $5M | |
| Interest Income | $703.0K | $1M | $868.0K | $964.0K | $1M | $1M | $830.0K | $794.0K | $1M | $3M | $3M | $1M | $604.0K | $1M | $604.0K | $425.0K | |
| Other Non-op | $109.0K | $742.0K | $252.0K | $80.0K | $-35.0K | $-48.0K | $381.0K | $-43.0K | $-105.0K | $8.0K | $-220.0K | $-77.0K | $-26.0K | $-220.0K | $-73.0K | $-345.0K | |
| Pretax Income | $-26M | $-26M | $-431M | $-20M | $-21M | $-63M | $-24M | $-24M | $1M | $-17M | $-48M | $-31M | $-35M | $-88M | $-10M | $-43M | |
| Income Tax | $3M | $910.0K | $-2M | $906.0K | $-825.0K | $1M | $-1M | $-619.0K | $-238.0K | $565.0K | $-15M | $-6M | $-970.0K | $-68M | $1M | $-46M | |
| Net Income | $-28M | $-27M | $-429M | $-21M | $-20M | $-65M | $-23M | $-23M | $2M | $-17M | $-33M | $-25M | $-34M | $-20M | $-11M | $2M | |
| EPS (Basic) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 | $-0.06 | $-0.22 | $-0.37 | $-0.30 | $-0.37 | $-0.24 | $-0.11 | $0.02 | |
| EPS (Diluted) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 | $-0.06 | $-0.22 | $-0.37 | $-0.30 | $-0.37 | $-0.24 | $-0.11 | $0.02 | |
| Shares (Basic) | 112,542,000 | 111,905,000 | · | 114,066,000 | 115,882,000 | 115,315,000 | · | 114,862,000 | 114,688,000 | 114,141,000 | · | 112,282,000 | 111,278,000 | 107,783,000 | · | 95,286,000 | |
| Shares (Diluted) | 112,542,000 | 111,905,000 | · | 114,066,000 | 115,882,000 | 115,315,000 | · | 114,862,000 | 114,688,000 | 114,141,000 | · | 112,282,000 | 111,278,000 | 107,783,000 | · | 99,308,000 | |
| EBITDA | $-10M | $11M | · | $886.0K | $-1M | $22M | · | $-16M | $8M | $16M | · | $-18M | $-22M | $19M | · | $13M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $116M | $142M | $152M | $117M | $151M | $247M | $104M | $97M | $101M | $165M | · | $185M | $143M | $158M | · | $157M | |
| Receivables | $449M | $314M | $310M | $387M | $359M | $430M | $415M | $408M | $374M | $428M | · | $394M | $345M | $263M | · | $188M | |
| Prepaid Expense | $23M | $22M | $19M | $22M | $28M | $35M | $29M | $23M | $26M | $25M | · | $37M | $41M | $34M | · | $24M | |
| Current Assets | $611M | $502M | $506M | $570M | $562M | $728M | $607M | $544M | $521M | $669M | · | $639M | $577M | $476M | · | $394M | |
| PP&E (Net) | $82M | $81M | $81M | $80M | $77M | $74M | $73M | $74M | $75M | $76M | · | $80M | $84M | $89M | · | $95M | |
| PP&E (Gross) | $298M | $293M | $287M | $280M | $271M | $261M | $253M | $247M | $241M | $234M | · | $255M | $250M | $247M | · | $236M | |
| Accum. Depreciation | $216M | $212M | $206M | $200M | $193M | $187M | $180M | $173M | $166M | $158M | · | $175M | $167M | $159M | · | $142M | |
| Goodwill | $694M | $694M | $694M | $1.08B | $1.14B | $1.14B | $1.14B | $1.14B | $1.12B | $1.12B | $1.12B | $1.12B | $1.12B | $1.12B | $723M | $723M | |
| Intangibles | $554M | $570M | $585M | $624M | $651M | $668M | $680M | $697M | $711M | $731M | · | $778M | $802M | $826M | · | $451M | |
| Total Assets | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | $2.65B | $2.54B | $2.50B | $2.48B | $2.64B | · | $2.67B | $2.65B | $2.59B | · | $1.76B | |
| Accounts Payable | $39M | $63M | $60M | $72M | $69M | $58M | $96M | $50M | $39M | $77M | · | $52M | $77M | $51M | · | $62M | |
| Accrued Liabilities | $44M | $45M | $66M | $61M | $64M | $100M | $66M | $120M | $85M | $165M | · | $194M | $167M | $170M | · | $132M | |
| Short-term Debt | · | · | $0 | $5M | $172M | $172M | $171M | · | · | · | · | $991.0K | · | · | · | · | |
| Current Liabilities | $493M | $381M | $385M | $430M | $558M | $739M | $716M | $524M | $483M | $659M | · | $615M | $541M | $458M | · | $382M | |
| Capital Leases | $2M | $3M | $4M | $4M | $8M | $16M | $25M | $29M | $31M | $32M | · | $40M | $57M | $54M | · | $58M | |
| Deferred Tax | $10M | $8M | $8M | $10M | $10M | $11M | $11M | $12M | $13M | $13M | · | $27M | $34M | $36M | · | $4M | |
| Other Non-current Liabilities | $8M | $8M | $8M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Liabilities | $1.59B | $1.48B | $1.48B | $1.61B | $1.34B | $1.52B | $1.35B | $1.28B | $1.24B | $1.41B | · | $1.40B | $1.38B | $1.30B | · | $903M | |
| Total Debt | $966M | $973M | · | $1.06B | $821M | $819M | · | $600M | $599M | $598M | · | $601M | $633M | $632M | · | $412M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.82B | $1.80B | $1.79B | $1.79B | $1.78B | $1.80B | $1.80B | $1.82B | $1.81B | $1.81B | · | $1.80B | $1.77B | $1.77B | · | $1.47B | |
| Retained Earnings | $-1.37B | $-1.34B | $-1.32B | $-886M | $-865M | $-845M | $-781M | $-758M | $-735M | $-736M | · | $-686M | $-660M | $-626M | · | $-595M | |
| Treasury Stock | $61M | $61M | $61M | $61M | $21M | $21M | $21M | $21M | $21M | $21M | · | $21M | $21M | $21M | · | $21M | |
| AOCI | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | · | $-1M | $-1M | $-1M | · | $-1M | |
| Stockholders' Equity | $383M | $396M | $415M | $842M | $896M | $936M | $1.00B | $1.04B | $1.05B | $1.05B | $1.07B | $1.10B | $1.09B | $1.12B | $859M | $856M | |
| Liabilities + Equity | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | $2.65B | $2.54B | $2.50B | $2.48B | $2.64B | · | $2.67B | $2.65B | $2.59B | · | $1.76B |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $22M | $45M | $24M | $23M | $24M | $29M | $30M | $30M | $30M | $30M | $32M | $32M | $29M | $20M | $17M | |
| Stock-based Comp | $15M | $11M | $2M | $15M | $12M | $11M | $-6M | $14M | $13M | $19M | $11M | $10M | $9M | $11M | $15M | $7M | |
| Amort. of Intangibles | $15M | $15M | $39M | $17M | $17M | $17M | $22M | $22M | $22M | $22M | $22M | $24M | $24M | $21M | $11M | $10M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | · | $-7M | · | · | · | $34M | · | · | · | $-26M | · | · | · | $-22M | · | · | |
| Operating Cash Flow | $-9M | $-984.0K | $49M | $16M | $-30M | $5M | $-26M | $19M | $21M | $5M | $89M | $61M | $654.0K | $-8M | $36M | $-3M | |
| Investing Cash Flow | $-7M | $-6M | $82M | $-9M | $-61M | $-13M | $-20M | $-20M | $-14M | $-10M | $-6M | $-6M | $-8M | $-395M | $-4M | $-255M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $-267.0K | $256M | · | $220M | |
| Net Debt Issued | · | · | · | · | · | $-62M | · | · | · | $0 | · | · | · | $219M | · | · | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-11M | $-4M | $-93M | $-42M | $-9M | $108M | $97M | $-9M | $-103M | $15M | $-84M | $-37M | $23M | $380M | $-11M | $173M | |
| Net Change in Cash | $-27M | $-12M | $38M | $-35M | $-100M | $99M | $51M | $-10M | $-96M | $10M | $-1M | $17M | $16M | $-23M | $20M | $-86M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1.5% | -2.1% | · | 0.18% | -0.26% | -0.34% | · | -2.6% | 1.2% | -2.1% | · | -3.5% | -4.6% | -2.4% | · | 3.7% | |
| Net Margin | -4.3% | -5.4% | · | -4.3% | -4.5% | -13.4% | · | -3.7% | 0.25% | -2.7% | · | -5.0% | -7.3% | -6.1% | · | 0.60% | |
| Pretax Margin | -3.9% | -5.2% | · | -4.2% | -4.7% | -13.1% | · | -3.8% | 0.21% | -2.6% | · | -6.0% | -7.5% | -20.6% | · | -12.3% | |
| EBITDA Margin | -1.5% | 2.2% | · | 0.18% | -0.26% | 4.6% | · | -2.6% | 1.2% | 2.5% | · | -3.5% | -4.6% | 4.4% | · | 3.7% | |
| ROA | -1.3% | -1.2% | · | -0.84% | -0.81% | -2.4% | · | -0.89% | 0.06% | -0.66% | · | -1.1% | -1.7% | -1.3% | · | 0.14% | |
| ROE | -4.4% | -4.0% | · | -2.2% | -2.0% | -6.5% | · | -2.2% | 0.15% | -1.6% | · | -2.6% | -4.0% | -3.0% | · | 0.29% | |
| ROIC | -0.78% | -0.80% | · | 0.05% | -0.07% | -0.09% | · | -0.97% | 0.55% | -0.84% | · | -0.87% | -1.2% | -0.13% | · | -0.05% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | · | 1.3 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | |
| Quick Ratio | 1.1 | 1.2 | · | 1.2 | 0.9 | 0.9 | · | 1.0 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.5 | 2.5 | · | 1.3 | 0.9 | 0.9 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 2.5 | 2.5 | · | 1.3 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -2.2 | · | -1.2 | -1.5 | -0.8 | · | 2.7 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.5 | 1.8 | 1.9 | · | 1.8 | 2.0 | 1.9 | · | 1.9 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.80 | $4.43 | · | $4.20 | $3.83 | $4.19 | · | $5.41 | $5.64 | $5.60 | · | $4.55 | $4.22 | $3.97 | · | $3.55 | |
| Cash Flow / Share | · | $-0.01 | · | · | · | $0.04 | · | · | · | $0.04 | · | · | · | $-0.07 | · | · | |
| EPS (TTM) | $-4.57 | $-4.76 | · | $-1.58 | $-1.61 | $-1.23 | · | $-0.92 | $-0.95 | $-1.26 | · | $-1.02 | $-0.70 | $-0.38 | · | $-0.15 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.10B | $1.89B | · | $2.05B | $2.20B | $2.40B | · | $2.46B | $2.35B | $2.18B | · | $1.79B | $1.63B | $1.48B | · | $1.22B | |
| Net Income TTM | $-505M | $-497M | · | $-128M | $-130M | $-109M | · | $-72M | $-74M | $-110M | · | $-91M | $-64M | $-34M | · | $-13M | |
| P/E | -1.2 | -0.5 | · | -5.4 | -7.0 | -7.7 | · | -30.7 | -20.1 | -26.0 | · | -26.7 | -43.3 | -85.4 | · | -239.5 | |
| Earnings Yield | -84.3% | -208.8% | · | -18.7% | -14.3% | -13.0% | · | -3.2% | -5.0% | -3.8% | · | -3.8% | -2.3% | -1.2% | · | -0.42% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $1.88B | $2.55B | $1.96B | $1.35B | $908M |
| Marża Operacyjna % | -21.9% | -1.6% | · | · | -4.7% |
| Zysk netto | $-535M | $-62M | $-113M | $-19M | $-38M |
| Rozwodniony EPS | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 2.3 | 0.7 | 0.6 | 0.5 | 0.3 |
| Wskaźnik bieżący | 1.3 | 0.8 | 1.0 | 1.1 | 1.2 |
| Wskaźnik Szybkości | 1.2 | 0.7 | 0.9 | 1.0 | 0.9 |
Brak danych dla tego sprawozdania
Zbyt mało danych fundamentalnych, aby utworzyć to sprawozdanie.
Właściciele instytucjonalni (13F) 218 emitentów · $665.3M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
218
Wartość posiadanych akcji
$665.3M
Nowe pozycje
36
Zamknięte pozycje
29
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 36 (-7 vs poprzedni kw.) | 29 (-24 vs poprzedni kw.) | 72 (+13 vs poprzedni kw.) | 64 (+2 vs poprzedni kw.) | +1.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $80 296 492 | 14 814 851 | 12,07% | Akcje |
| CADIAN CAPITAL MANAGEMENT, LP | $58 614 444 | 10 814 473 | 8,81% | Akcje |
| MORGAN STANLEY | $48 612 048 | 8 969 012 | 7,31% | Akcje |
| VANGUARD GROUP INC | $35 656 260 | 8 914 065 | 5,36% | Akcje |
| UBS Group AG | $33 849 434 | 6 245 283 | 5,09% | Akcje |
| Rubicon Founders LLC | $31 523 387 | 5 816 123 | 4,74% | Akcje |
| Engaged Capital LLC | $30 156 403 | 5 563 912 | 4,53% | Akcje |
| D. E. Shaw & Co., Inc. | $27 682 981 | 5 107 561 | 4,16% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $25 950 927 | 4 787 994 | 3,90% | Akcje |
| MARSHALL WACE, LLP | $18 499 786 | 3 413 245 | 2,78% | Akcje |
| Nuveen, LLC | $16 975 900 | 3 132 085 | 2,55% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $15 748 879 | 2 904 912 | 2,37% | Akcje |
| Rock Springs Capital Management LP | $13 550 000 | 2 500 000 | 2,04% | Akcje |
| STATE STREET CORP | $13 335 536 | 2 460 431 | 2,00% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 553 126 | 2 131 573 | 1,74% | Akcje |
| Glenmede Investment Management, LP | $10 477 514 | 1 238 477 | 1,57% | Akcje |
| Camber Capital Management LP | $9 571 000 | 850 000 | 1,44% | Akcje |
| GOLDMAN SACHS GROUP INC | $9 462 518 | 1 745 852 | 1,42% | Akcje |
| Rock Point Advisors, LLC | $9 321 782 | 1 719 886 | 1,40% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $8 680 878 | 1 601 638 | 1,30% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $8 497 563 | 1 567 816 | 1,28% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7 305 195 | 1 347 822 | 1,10% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $6 920 256 | 1 276 800 | 1,04% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $6 848 999 | 1 263 653 | 1,03% | Akcje |
| NORTHERN TRUST CORP | $5 437 589 | 1 003 245 | 0,82% | Akcje |
| Hudson Bay Capital Management LP | $4 949 051 | 913 109 | 0,74% | Akcje |
| BANK OF AMERICA CORP /DE/ | $4 744 657 | 875 398 | 0,71% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $4 663 140 | 860 358 | 0,70% | Akcje |
| Walleye Capital LLC | $4 584 166 | 845 787 | 0,69% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $4 296 803 | 792 768 | 0,65% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $4 149 028 | 765 020 | 0,62% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $4 132 002 | 762 362 | 0,62% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $3 790 027 | 699 267 | 0,57% | Akcje |
| Voleon Capital Management LP | $3 612 441 | 666 502 | 0,54% | Akcje |
| Cubist Systematic Strategies, LLC | $3 564 938 | 421 387 | 0,54% | Akcje |
| ALGERT GLOBAL LLC | $3 558 029 | 656 463 | 0,53% | Akcje |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $3 414 600 | 630 000 | 0,51% | Akcje |
| Man Group plc | $2 700 634 | 498 272 | 0,41% | Akcje |
| CITADEL ADVISORS LLC | $2 649 372 | 488 814 | 0,40% | Akcje |
| FORMULA GROWTH LTD | $2 628 700 | 485 000 | 0,40% | Akcje |
| CITIGROUP INC | $2 521 091 | 465 146 | 0,38% | Akcje |
| Tejara Capital Ltd | $2 392 692 | 441 456 | 0,36% | Akcje |
| Invesco Ltd. | $2 247 036 | 414 582 | 0,34% | Akcje |
| Jump Financial, LLC | $2 103 448 | 388 090 | 0,32% | Akcje |
| Mariner, LLC | $2 015 099 | 371 753 | 0,30% | Akcje |
| Benefit Street Partners LLC | $1 968 354 | 363 165 | 0,30% | Akcje |
| Bank of New York Mellon Corp | $1 867 883 | 344 628 | 0,28% | Akcje |
| Creative Planning | $1 788 692 | 330 017 | 0,27% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 644 119 | 303 343 | 0,25% | Akcje |
| BRIGHTON JONES LLC | $1 593 998 | 294 096 | 0,24% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest XI, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×6 zgłoszenia | 25 sierpnia 2022 | · | Pierwotne zgłoszenie | · | SEC |
| UnitedHealth Group Incorporated, The Advisory Board Company ×2 zgłoszenia | 5 marca 2018 | · | Pierwotne zgłoszenie | Kampania zarządu | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 37 insiderów · 15 dyrektorzy generalni · 21 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Seth Blackley | Chief Executive Officer | 1 lipca 2026 F | 1 272 767 | 0 | 0 | $0 |
| Steve Wigginton | CEO, Valence Health | 1 sierpnia 2017 M | 12 411 | 0 | 0 | $0 |
| Mario Ramos | Chief Financial Officer | 2 marca 2026 A | 587 500 | 0 | 0 | $0 |
| John Paul Johnson | Chief Financial Officer | 1 lipca 2025 A | 309 245 | 0 | 0 | $0 |
| Nicholas Mcgrane | Chief Financial Officer | 1 marca 2019 A | 84 088 | 0 | 0 | $0 |
| Daniel Joseph Mccarthy | PRESIDENT | 26 sierpnia 2026 S | 655 133 | 0 | 1 | $-329 460 |
| Emily Ann Rafferty | Chief Operating Officer | 3 marca 2025 F | 130 128 | 0 | 0 | $0 |
| Steve Tutewohl | Chief Operating Officer | 1 lipca 2023 A | 136 331 | 0 | 0 | $0 |
| Thomas Peterson III | Chief Operating Officer | 1 marca 2019 A | 67 868 | 0 | 0 | $0 |
| Aammaad Shams | Chief Accounting Officer | 1 lipca 2026 A | 95 637 | 0 | 0 | $0 |
| Jonathan Weinberg | General Counsel | 1 lipca 2026 F | 284 917 | 0 | 0 | $0 |
| Lydia Stone | Chief Accounting Officer | 2 marca 2020 A | 48 855 | 0 | 0 | $0 |
| Dave Thornton | Chief Talent Officer | 14 września 2016 S | 95 457 | 0 | 0 | $0 |
| Chad Pomeroy | Chief Technology Officer | 14 września 2016 S | 286 370 | 0 | 0 | $0 |
| Gary Piefer | Chief Medical Officer | 10 czerwca 2015 P | 206 269 | 0 | 0 | $0 |
| Russell Monroe Glass | Dyrektor | 4 czerwca 2026 A | 77 347 | 0 | 0 | $0 |
| Toyin Ajayi | Dyrektor | 4 czerwca 2026 A | 75 170 | 0 | 0 | $0 |
| Kim Keck | Dyrektor | 4 czerwca 2026 A | 102 597 | 0 | 0 | $0 |
| Richard M Jelinek | Dyrektor | 4 czerwca 2026 A | 77 533 | 0 | 0 | $0 |
| Brendan B Springstubb | Dyrektor | 4 czerwca 2026 A | 99 917 | 1 | 0 | $38 200 |
| Craig A. Barbarosh | Dyrektor | 4 czerwca 2026 A | 95 031 | 0 | 0 | $0 |
| Jill D. Smith | Dyrektor | 4 czerwca 2026 A | 64 233 | 0 | 0 | $0 |
| Peter J Grua | Dyrektor | 4 czerwca 2026 A | 63 075 | 0 | 0 | $0 |
| Shawn M Guertin | Dyrektor | 4 czerwca 2026 A | 63 075 | 0 | 0 | $0 |
| Cheryl Scott | Dyrektor | 5 czerwca 2025 A | 73 476 | 0 | 0 | $0 |
| Diane Holder | Dyrektor | 6 marca 2025 P | 70 584 | 0 | 0 | $0 |
| Mary Bridget Duffy | Dyrektor | 6 czerwca 2024 A | 48 001 | 0 | 0 | $0 |
| Tunde Sotunde | Dyrektor | 8 czerwca 2023 A | 14 018 | 0 | 0 | $0 |
| Frank J Williams | Dyrektor | 1 czerwca 2023 M | 819 812 | 0 | 0 | $0 |
| David Farner | Dyrektor | 9 czerwca 2022 A | 67 091 | 0 | 0 | $0 |
| Michael D'Amato | Dyrektor | 10 czerwca 2021 A | 93 455 | 0 | 0 | $0 |
| Bruce C. Felt Jr. | Dyrektor | 9 czerwca 2020 A | 53 742 | 0 | 0 | $0 |
| Kenneth A Samet | Dyrektor | 15 sierpnia 2019 P | 39 235 | 0 | 0 | $0 |
| Norman Payson | Dyrektor | 13 czerwca 2018 A | 21 284 | 0 | 0 | $0 |
| UNITEDHEALTH GROUP INC | Dyrektor | 1 czerwca 2018 S | 0 | 0 | 0 | $0 |
| UPMC | Posiadacz 10% | 19 maja 2017 S | 6 434 283 | 0 | 0 | $0 |
| ADVISORY BOARD CO | Posiadacz 10% | 19 maja 2017 C | 4 128 167 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 21 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| JSML · Janus Detroit Street Trust | 0,30% | 353 725 NS | 31 lipca 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,24% | 814 328 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,18% | 287 524 SH | 19 sierpnia 2026 | Dziennie |
| IHF · iShares Trust | 0,07% | 217 647 SH | 11 września 2026 | Dziennie |
| HAPS · Harbor ETF Trust | 0,06% | 32 306 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 384 327 SH | 1 października 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 64 467 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 659 586 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,02% | 2 931 653 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 54 743 NS | 31 lipca 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 381 420 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 299 653 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 43 642 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 283 197 SH | 19 sierpnia 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,00% | 111 300 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 142 347 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 29 771 SH | 3 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 7 074 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 384 855 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 406 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 683 840 SH | 11 września 2026 | Dziennie |
EVH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 19 analityków
KUP
Średni cel
$6.00
+73,4%
5 26,3%
Mocne kupno
10 52,6%
Kup
4 21,1%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
12 analityków · 2026-09-29Średnia cel $5.75 +66,2%
Teraz
Aktualna cena $3.46
Niski$3.00
Średnia$5.75
Wysoki$8.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| EVH | · | -0.8 | -26.6% | -28.5% | -81.5% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
| SLP | $285M | -4.4 | 13.1% | -81.7% | -41.2% | 58.4% |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | · |
| AMWL | $81M | -0.8 | -2.0% | -38.4% | -35.4% | · |
| OPRX | $230M | 45.4 | 18.8% | 4.7% | 4.2% | 67.2% |
| DH | · | -2.2 | -4.2% | -57.5% | -28.2% | 75.9% |
| LFMD | $159M | 13.6 | 25.3% | 7.4% | 204.0% | 85.7% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026